Loading company details...
Latest Form 4 (Oct 15, 2025): David Ross Parkinson (President and CEO): Disposition to Issuer of 65,675 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2025 | David Ross Parkinson, President and CEO | Disposition to Issuer | 65,675 | n/a |
| Oct 15, 2025 | David S. Wood, Chief Financial Officer | Disposition to Issuer | 33,343 | n/a |
| Oct 15, 2025 | Franklin M. Berger | Disposition to Issuer | 784,404 | n/a |
| Oct 15, 2025 | Richard M. Glickman | Disposition to Issuer | 43,240 | n/a |
| Oct 15, 2025 | Scott Requadt | Disposition to Issuer | 30,002 | n/a |
| Oct 15, 2025 | John Alexander Martin | Disposition to Issuer | 14,299 | n/a |
| Oct 15, 2025 | Marella Thorell | Disposition to Issuer | 2,881 | n/a |
| Oct 14, 2025 | BVF PARTNERS L P/IL | Tender of Shares | 6,194,145 | n/a |
| Aug 7, 2025 | BVF PARTNERS L P/IL | In-the-Money Exercise | 1,481,634 | $148.16 |
| Nov 5, 2024 | Growth N. Biotech V | Sale | 2,000,000 | $3.06M |